14 unchanged sentences
The stock price performance included in this graph is not necessarily indicative of future stock price performance.
+Added: Table of Content s
Recent Sales of Unregistered Securities
Purchases of Equity Securities by the Issuer or Affiliated Purchasers
−Removed: On March 25, 2021, we announced that our board of directors authorized a share repurchase program to purchase up to $1.2 billion of our outstanding shares of common stock, or the Repurchase Program.
−Removed: Under the Repurchase Program, we are authorized to repurchase shares through open market purchases, privately negotiated block sales and through Rule 10b5-1 repurchase plans.
−Removed: The Repurchase Program has no expiration date.
−Removed: On March 31, 2021, in connection with the Repurchase Program, we entered into a definitive share repurchase agreement with BMS to repurchase 7.1 million shares of our common stock held by certain subsidiaries of BMS for an aggregate purchase price of $344.5 million, or $48.38 per share.
+Added: On March 25, 2021, we announced that our Board of Directors authorized the repurchase of up to $1.2 billion of our outstanding shares of common stock, or the Repurchase Program, using the proceeds from the sale of our oncology business to Servier.
+Added: On March 31, 2021, in connection with the Repurchase Program, we entered into a definitive share repurchase agreement with Bristol Myers Squibb Company, or BMS, to repurchase 7.1 million shares of our common stock held by certain subsidiaries of BMS for an aggregate purchase price of $344.5 million, or $48.38 per share.
This repurchase was completed on April 5, 2021.
−Removed: On April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan to repurchase up to $600 million of shares of our common stock of the $1.2 billion shares authorized.
−Removed: As of December 31, 2021, we have repurchased approximately 9.1 million shares of common stock for $458.0 million, or $50.35 per share, under the Rule 10b5-1 repurchase plan.
−Removed: In total, as of December 31, 2021, we have repurchased 16.2 million shares of common stock for $802.5 million, or $49.49 per share, under the Repurchase Program.
−Removed: On October 5, 2021, we terminated our Rule 10b5-1 share repurchase plan and on October 13, 2021 we entered into a Rule 10b-18 repurchase plan that allows us to conduct open market repurchases over time up to our remaining authorization under the Repurchase Program.
+Added: Further, on April 2, 2021, in connection with the Repurchase Program, we entered into a Rule 10b5-1 repurchase plan pursuant to which we could repurchase up to $600.0 million of shares of our common stock.
+Added: On October 5, 2021, we terminated our Rule 10b5-1 share repurchase program and on October 13, 2021 entered into a Rule 10b-18 repurchase plan that allows us to conduct open market repurchases over time up to our remaining authorization under the Repurchase Program.
+Added: We have not repurchased any shares of common stock in fiscal year 2022 and as of December 31, 2021, we repurchased approximately 9.1 million shares of common stock for $458.0 million, or $50.35 per share, under the Rule 10b5-1 repurchase plan.
As of December 31, 2022, we have not repurchased any shares under the Rule 10b-18 repurchase plan.
+Added: In total, as of December 31, 2022, we repurchased 16.2 million shares of common stock for $802.5 million, or $49.49 per share, under the Repurchase Program.
The amount and timing of share repurchases are subject to capital availability, our cash balances and future capital requirements, and our determination that share repurchases are in the best interest of our stockholders and are in compliance with all respective laws and our applicable agreements.
We have paused our share repurchases and for the foreseeable future, we expect that our capital allocation will be prioritized towards opportunities to accelerate programs in our development pipeline and/or pursue potential complementary business development opportunities.
−Removed: The table below summarizes the repurchases made under our Repurchase Program during the three months ended December 31, 2021:
−Removed: Issuer Purchases of Equity Securities
−Removed: Part of Publicly
−Removed: Announced Plans
−Removed: or Programs (1)
−Removed: Dollar Value of
−Removed: Shares that May
−Removed: Yet Be Purchased
−Removed: Under the Plans
−Removed: (in millions)
−Removed: October 1, 2021 through October 31, 2021
−Removed: 416,259 $ 45.76 416,259 $ 397.5
−Removed: November 1, 2021 through November 30, 2021
−Removed: December 1, 2021 through December 31, 2021 — $ — — $ —
−Removed: 416,259 $ 45.76 416,259
−Removed: (1) All shares repurchased by us during the three months ended December 31, 2021, were repurchased pursuant to the Repurchase Program, as described above.
+Added: Table of Content s
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.